Lataa...
Use of Cannabinoids as a Novel Therapeutic Modality Against Autoimmune Hepatitis
Autoimmune hepatitis is a severe immune mediated chronic liver disease with a prevalence range between 50 and 200 cases per million in Western Europe and North America and mortality rates of up to 80% in untreated patients. The induction of CB1 and CB2 cannabinoid receptors during liver injury and t...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139007/ https://ncbi.nlm.nih.gov/pubmed/19647124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0083-6729(09)81019-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|